UK Odontogenic Tumor Market

ID: MRFR/HC/55161-HCR 200 Pages Rahul Gotadki Last Updated: September 17, 2026
UK Odontogenic Tumor Market Research Report By Tumor Type (Malignant Odontogenic Tumor, Others), By Diagnosis (Computerized Tomography Scan, Others), By Treatment (Surgery, Others) and By End-Users (Dental Clinics, Hospitals, Others) - Growth & Industry Forecast 2025 To 2035
UK Odontogenic Tumor Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.43%
2024 Market Size$ 23.1 Million
2025 Market Size$ 24.59 Million
2035 Market Size$ 45.86 Million
Key Players
Dentsply Sirona
Straumann
Henry Schein
Danaher Corporation
3M
Nobel Biocare
Trends
  • Technological Advancements in Diagnosis
  • Increased Research Funding
  • Rising Awareness and Education
Opportunities
  • Advancements in Treatment Modalities
  • Growing Incidence of Odontogenic Tumors
  • Rising Demand for Oral Health Awareness
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Type (USD Million)
      1. 4.1.1 Malignant Odontogenic Tumors
      2. 4.1.2 Benign Odontogenic Tumors
    2. 4.2 Healthcare, BY Diagnosis (USD Million)
      1. 4.2.1 Computerized tomography scan
      2. 4.2.2 Magnetic resonance imaging
      3. 4.2.3 Biopsy
    3. 4.3 Healthcare, BY Treatment (USD Million)
      1. 4.3.1 Surgery
      2. 4.3.2 Radiation therapy
      3. 4.3.3 Chemotherapy
    4. 4.4 Healthcare, BY End-User (USD Million)
      1. 4.4.1 Dental laboratories
      2. 4.4.2 Dental hospitals and clinics
      3. 4.4.3 Dental academic and research institutes
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Dentsply Sirona (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Straumann (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Henry Schein (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Danaher Corporation (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 3M (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Nobel Biocare (CH)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Mediware (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Kavo Kerr (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 UK MARKET ANALYSIS BY TYPE
    3. 6.3 UK MARKET ANALYSIS BY DIAGNOSIS
    4. 6.4 UK MARKET ANALYSIS BY TREATMENT
    5. 6.5 UK MARKET ANALYSIS BY END-USER
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 HEALTHCARE, BY DIAGNOSIS, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
    16. 6.16 HEALTHCARE, BY TREATMENT, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY TREATMENT, 2024 TO 2035 (USD Million)
    18. 6.18 HEALTHCARE, BY END-USER, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
      3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

UK UK Odontogenic Tumor Market Segmentation

UK Odontogenic Tumor Market By Type (USD Million, 2025-2035)

  • Malignant Odontogenic Tumors
  • Benign Odontogenic Tumors

UK Odontogenic Tumor Market By Diagnosis (USD Million, 2025-2035)

  • Computerized tomography scan
  • Magnetic resonance imaging
  • Biopsy

UK Odontogenic Tumor Market By Treatment (USD Million, 2025-2035)

  • Surgery
  • Radiation therapy
  • Chemotherapy

UK Odontogenic Tumor Market By End-User (USD Million, 2025-2035)

  • Dental laboratories
  • Dental hospitals and clinics
  • Dental academic and research institutes

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.